Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zdeňka Hajšmanová"'
Autor:
Marcela Kralovcova, Jiri Müller, Zdenka Hajsmanova, Pavla Sigutova, Lenka Bultasova, Jana Palatova, Martin Matejovic
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract The monocyte distribution width (MDW) has emerged as a promising biomarker for accurate and early identification of patients with potentially life-threatening infections. Here we tested the diagnostic performance of MDW in adult patients req
Externí odkaz:
https://doaj.org/article/0bd3f83a245f4788b902e859ff6e69f9
Autor:
Antonin Hlusi, Ester Zápotocká, Petr Smejkal, Jan Blatný, R. Hrdličková, Miroslav Penka, Zdeňka Hajšmanová
Publikováno v:
Transfuze a hematologie dnes. 27:73-90
Publikováno v:
Journal of vascular surgery. Venous and lymphatic disorders. 10(1)
The objective of the present study was to evaluate the prevalence of cancer in patients with superficial vein thrombosis (SVT) of the legs. Moreover, we evaluated the potential determinants of SVT complications by comparing a subgroup with isolated S
Publikováno v:
Hämostaseologie. 38:39-42
Idarucizumab is designed to reverse the anticoagulant effect of dabigatran. This case report describes the administration of three independent doses of idarucizumab to a 76-year-old man suffering from atrial flutter being treated with dabigatran to p
Publikováno v:
Casopis lekaru ceskych. 155(8)
Dabigatran (Pradaxa, Boehringer Ingelheim) is the first direct oral thrombin (FIIa) inhibitor. It is indicated for thromboprophylaxis in patients undergoing elective total replacement hip or knee joint surgery or for the primary or secondary prophyla